Quoin Pharmaceuticals reports interim Phase 2/3 data for QRX003

August 28, 2026 6:00 AM

Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) announced interim results from its ongoing Phase 2/3 study of QRX003 4% lotion in patients ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found